Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

5.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

7.3K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective Analysis of the Impact of the "Escape from Flatland" Publication on the Merck & Co., Inc., Small Molecule Portfolio.

Journal of medicinal chemistry·2026
Same author

Targeted use of Prostaglandin E1 Therapy in "Duct-dependent" Congenital Diaphragmatic Hernia.

American journal of respiratory and critical care medicine·2026
Same author

Metastatic Melanoma Presenting as an Orbital Mass.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Cancerous Arrhythmia: Metastatic Cervical Cancer to the Heart Complicated by Ventricular Tachycardia.

JACC. Case reports·2026
Same author

A student-led pilot lecture in nutrition as a catalyst for curriculum change: A case study from one medical school.

PloS one·2026
Same author

Left P-Wave Axis Deviation: A Clue for Cardiovascular Malformation?

JACC. Case reports·2026

Related Experiment Video

Updated: Jul 20, 2025

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation
07:15

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation

Published on: November 26, 2011

17.9K

Structural insights into selective small molecule activation of PKG1α.

Essam Metwally1, Victor Mak2, Aileen Soriano3

  • 1Modeling and Informatics, MRL, Merck & Co., Inc., 213 E. Grand Avenue, South San Francisco, CA, USA. essam.metwally@merck.com.

Communications Biology
|July 31, 2023
PubMed
Summary

Researchers discovered small molecules that activate cGMP-dependent protein kinase I-α (PKG1α) independently of cGMP. These molecules bind to an allosteric site, revealing a new activation mechanism for this pulmonary arterial hypertension therapeutic target.

More Related Videos

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
11:20

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation

Published on: August 30, 2017

7.5K
Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

8.5K

Related Experiment Videos

Last Updated: Jul 20, 2025

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation
07:15

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation

Published on: November 26, 2011

17.9K
An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
11:20

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation

Published on: August 30, 2017

7.5K
Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

8.5K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • cGMP-dependent protein kinase I-α (PKG1α) is a key regulator of smooth muscle function and a therapeutic target for pulmonary arterial hypertension.
  • Current research primarily focuses on regulating cGMP turnover for PKG1α modulation.

Purpose of the Study:

  • To identify and characterize novel small molecules that activate PKG1α through a cGMP-independent pathway.
  • To elucidate the structural basis and mechanism of activation for these novel PKG1α activators.

Main Methods:

  • Small molecule screening and characterization.
  • Crystallization of PKG1α in complex with tool compounds.
  • X-ray crystallography to determine binding site and structural changes.

Main Results:

  • Several small molecule tool compounds were identified that activate PKG1α independently of cGMP.
  • Crystallographic analysis revealed that these molecules bind to an allosteric site near the nucleotide-binding domain.
  • Ligand binding induces displacement of the switch helix, leading to PKG1α activation.

Conclusions:

  • A novel mechanism for PKG1α activation has been discovered, involving cGMP-independent allosteric modulation.
  • The identified small molecules and their binding structures provide critical insights into the regulation of PKG1α.
  • This discovery opens new avenues for therapeutic strategies targeting pulmonary arterial hypertension.